Notebook

HARDWIRED HUNGER Two distinct but adjacent sets of cells in the same part of the brain respond in opposite ways to the same hormone: leptin, which, when lacking in the bloodstream, results in a voracious appetite. A group led by Joel K. Elmquist, neuroendocrinology researcher at Beth Israel Deaconess Medical Center and assistant professor of neurology and medicine at Harvard Medical School, set out to understand the leptin pathway by injecting the hormone into rats and following its progress to

Written byPaul Smaglik
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

HARDWIRED HUNGER Two distinct but adjacent sets of cells in the same part of the brain respond in opposite ways to the same hormone: leptin, which, when lacking in the bloodstream, results in a voracious appetite. A group led by Joel K. Elmquist, neuroendocrinology researcher at Beth Israel Deaconess Medical Center and assistant professor of neurology and medicine at Harvard Medical School, set out to understand the leptin pathway by injecting the hormone into rats and following its progress to the lateral hypothalamus area, the part of the brain associated with appetite.In one cell type, leptin bound to neuropeptide Y (NPY), which releases peptides encouraging eating, and in the other cell type it bound to pro-opiomelanocortin (POMC), which releases peptides discouraging eating. Both neuronal cell types expressed SOCS-3, a gene that encodes a protein that acts as a negative feedback regulator of leptin receptor signaling, but only the POMC-expressing cells ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies